Lori Anne Kunkel - 08 Apr 2024 Form 3 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
Director
Signature
/s/ Ben Hohl, by power of attorney
Issuer symbol
ELVN
Transactions as of
08 Apr 2024
Transactions value $
$0
Form type
3
Filing time
10 Apr 2024, 20:37:20 UTC
Previous filing
15 Jun 2023
Next filing
20 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ELVN Common Stock 14.8K 08 Apr 2024 Direct
holding ELVN Common Stock 31.2K 08 Apr 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ELVN Stock Option (right to buy) 08 Apr 2024 Common Stock 19.7K $1.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Lori Kunkel Revocable Trust DTD 11/08/2018 Lori A Kunkel TTEE.
F2 Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Remarks:

Exhibit 24 - Power of Attorney